Act Genomics

Clinical and research services in genomics for cancer

placeTaipei, Taipei, Taiwan calendar_todayFounded 2014 groups300 employees language actgenomics.com

Social engagement

Social engagement: 6.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Kyoto University Innovation Capital, Aflac Innovation Partners, Hotung Investment Holdings, CDIB Capital.

Investor typeCountShare
Venture capital764%
Private equity19%
Accelerator & incubator19%
Other / undisclosed218%

Recent activity

20 Apr 2026
Product launch
ACTDrug® series (NGS) genomic profiling service
26 Feb 2026
Product launch
ACTMonitor® Breast
23 Feb 2026
Event
Gallbladder Cancer AwarenessMonth
Coming soon